Pure Global

REPİGO 400 MG I.M./I.V. POWDER AND SOLVENT FOR THE PREPARATION OF SOLUTION FOR INJECTION, 1 VIAL AND 1 AMPOULE - Turkey License 520ba23299e555776d103eff1f3ddad3

Access comprehensive regulatory information for REPİGO 400 MG I.M./I.V. POWDER AND SOLVENT FOR THE PREPARATION OF SOLUTION FOR INJECTION, 1 VIAL AND 1 AMPOULE in Turkey's pharmaceutical market through Pure Global AI's free database. This pharmaceutical product is licensed under Turkey number 520ba23299e555776d103eff1f3ddad3 with license number 2022/355and contains active ingredient Teicoplanin. The license is held by DEVA HOLDİNG A.Ş..

This page provides complete pharmaceutical specifications, regulatory compliance details. Pure Global AI offers free access to 21,000+ Turkish pharmaceutical product licenses, helping global pharma companies navigate Turkey SFDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
21,000+ Products
520ba23299e555776d103eff1f3ddad3
License Details
Turkey SFDA License: 520ba23299e555776d103eff1f3ddad3
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Product Details

REPİGO 400 MG I.M./I.V. POWDER AND SOLVENT FOR THE PREPARATION OF SOLUTION FOR INJECTION, 1 VIAL AND 1 AMPOULE
TR: REPİGO 400 MG I.M./I.V. ENJEKSİYONLUK ÇÖZELTİ HAZIRLAMAK İÇİN TOZ VE ÇÖZÜCÜ, 1 FLAKON VE 1 AMPUL
Pharmaceutical Product

License Details

520ba23299e555776d103eff1f3ddad3

2022/355

8699525798534

J01XA02

License Holder Information

Active Ingredient

Teicoplanin

License Information

Jun 30, 2022